Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 102

1.
2.

Better Pairing Propofol Volume With Procedural Needs: A Propofol Waste Reduction Quality Improvement Project.

Kicker JS, Hill HS, Matheson CK.

Hosp Pediatr. 2018 Oct;8(10):604-610. doi: 10.1542/hpeds.2018-0010. Epub 2018 Sep 11.

PMID:
30206112
3.

Pharmacist services for non-hospitalised patients.

de Barra M, Scott CL, Scott NW, Johnston M, de Bruin M, Nkansah N, Bond CM, Matheson CI, Rackow P, Williams AJ, Watson MC.

Cochrane Database Syst Rev. 2018 Sep 4;9:CD013102. doi: 10.1002/14651858.CD013102. Review.

PMID:
30178872
4.

Development of Potent Pyrazolopyrimidinone-Based WEE1 Inhibitors with Limited Single-Agent Cytotoxicity for Cancer Therapy.

Matheson CJ, Casalvieri KA, Backos DS, Reigan P.

ChemMedChem. 2018 Aug 20;13(16):1681-1694. doi: 10.1002/cmdc.201800188. Epub 2018 Jul 11.

PMID:
29883531
5.

'You are still a human being, you still have needs, you still have wants': a qualitative exploration of patients' experiences and views of HIV support.

Fingleton NA, Watson MC, Matheson C.

J Public Health (Oxf). 2018 Dec 1;40(4):e571-e577. doi: 10.1093/pubmed/fdy061.

PMID:
29608695
6.

Physicians' experiences of SBIRT training and implementation for SUD management in primary care in the UAE: a qualitative study.

Pflanz-Sinclair C, Matheson C, Bond CM, Almarzouqi A, Lee AJ, Batieha A, Al Ghaferi H, El Kashef A.

Prim Health Care Res Dev. 2018 Jul;19(4):344-354. doi: 10.1017/S1463423617000834. Epub 2017 Dec 26.

PMID:
29277167
7.

A controlled trial of screening, brief intervention and referral for treatment (SBIRT) implementation in primary care in the United Arab Emirates.

Matheson C, Pflanz-Sinclair C, Almarzouqi A, Bond CM, Lee AJ, Batieha A, Al Ghaferi H, El Kashef A.

Prim Health Care Res Dev. 2018 Mar;19(2):165-175. doi: 10.1017/S1463423617000640. Epub 2017 Oct 9.

PMID:
28988545
8.

Non-prescription medicine misuse, abuse and dependence: a cross-sectional survey of the UK general population.

Fingleton NA, Watson MC, Duncan EM, Matheson C.

J Public Health (Oxf). 2017 Dec 1;39(4):876. doi: 10.1093/pubmed/fdx085. No abstract available.

PMID:
28985351
9.

Selective Targeting of RSK Isoforms in Cancer.

Casalvieri KA, Matheson CJ, Backos DS, Reigan P.

Trends Cancer. 2017 Apr;3(4):302-312. doi: 10.1016/j.trecan.2017.03.004. Epub 2017 Apr 3. Review.

PMID:
28718440
10.

Nasal high flow oxygen therapy in the ward setting: A prospective observational study.

Pirret AM, Takerei SF, Matheson CL, Kelly M, Strickland W, Harford J, Jepsen NE, Welsh LJ, Allan CPA.

Intensive Crit Care Nurs. 2017 Oct;42:127-134. doi: 10.1016/j.iccn.2017.04.001. Epub 2017 Jun 16.

PMID:
28629636
11.

Changes in over-the-counter drug misuse over 20 years: perceptions from Scottish pharmacists.

Wright J, Bond C, Robertson HD, Matheson C.

J Public Health (Oxf). 2016 Dec 2;38(4):793-799. doi: 10.1093/pubmed/fdv169. No abstract available.

PMID:
28158745
12.

Non-prescription medicine misuse, abuse and dependence: a cross-sectional survey of the UK general population.

Fingleton NA, Watson MC, Duncan EM, Matheson C.

J Public Health (Oxf). 2016 Dec 2;38(4):722-730. doi: 10.1093/pubmed/fdv204. No abstract available.

PMID:
28158728
13.

Does the biopsychosocial-spiritual model of addiction apply in an Islamic context? A qualitative study of Jordanian addicts in treatment.

Ghaferi HA, Bond C, Matheson C.

Drug Alcohol Depend. 2017 Mar 1;172:14-20. doi: 10.1016/j.drugalcdep.2016.11.019. Epub 2016 Nov 23.

PMID:
28104541
14.

Cyclin-Dependent Kinase (CDK) Inhibitors: Structure-Activity Relationships and Insights into the CDK-2 Selectivity of 6-Substituted 2-Arylaminopurines.

Coxon CR, Anscombe E, Harnor SJ, Martin MP, Carbain B, Golding BT, Hardcastle IR, Harlow LK, Korolchuk S, Matheson CJ, Newell DR, Noble ME, Sivaprakasam M, Tudhope SJ, Turner DM, Wang LZ, Wedge SR, Wong C, Griffin RJ, Endicott JA, Cano C.

J Med Chem. 2017 Mar 9;60(5):1746-1767. doi: 10.1021/acs.jmedchem.6b01254. Epub 2017 Feb 14.

15.

Structure-guided design of purine-based probes for selective Nek2 inhibition.

Coxon CR, Wong C, Bayliss R, Boxall K, Carr KH, Fry AM, Hardcastle IR, Matheson CJ, Newell DR, Sivaprakasam M, Thomas H, Turner D, Yeoh S, Wang LZ, Griffin RJ, Golding BT, Cano C.

Oncotarget. 2017 Mar 21;8(12):19089-19124. doi: 10.18632/oncotarget.13249.

16.

Evaluation of quantitative assays for the identification of direct signal transducer and activator of transcription 3 (STAT3) inhibitors.

Furtek SL, Matheson CJ, Backos DS, Reigan P.

Oncotarget. 2016 Nov 22;7(47):77998-78008. doi: 10.18632/oncotarget.12868.

17.

Patterns and Impact of Hypoglycemia, Hyperglycemia, and Glucose Variability on Inpatients with Insulin-Treated Cystic Fibrosis-Related Diabetes.

Jones GC, Chong ZM, Gilmour J, Matheson C, MacGregor G, Sainsbury CA.

Diabetes Ther. 2016 Sep;7(3):575-82. doi: 10.1007/s13300-016-0194-7. Epub 2016 Aug 22.

18.

Targeting WEE1 Kinase in Cancer.

Matheson CJ, Backos DS, Reigan P.

Trends Pharmacol Sci. 2016 Oct;37(10):872-881. doi: 10.1016/j.tips.2016.06.006. Epub 2016 Jul 14. Review.

PMID:
27427153
19.

A WEE1 Inhibitor Analog of AZD1775 Maintains Synergy with Cisplatin and Demonstrates Reduced Single-Agent Cytotoxicity in Medulloblastoma Cells.

Matheson CJ, Venkataraman S, Amani V, Harris PS, Backos DS, Donson AM, Wempe MF, Foreman NK, Vibhakar R, Reigan P.

ACS Chem Biol. 2016 Jul 15;11(7):2066-7. doi: 10.1021/acschembio.6b00466. Epub 2016 Jun 15. No abstract available.

PMID:
27304454
20.

Resilience of primary healthcare professionals: a systematic review.

Robertson HD, Elliott AM, Burton C, Iversen L, Murchie P, Porteous T, Matheson C.

Br J Gen Pract. 2016 Jun;66(647):e423-33. doi: 10.3399/bjgp16X685261. Epub 2016 May 9. Review.

21.

Resilience of primary healthcare professionals working in challenging environments: a focus group study.

Matheson C, Robertson HD, Elliott AM, Iversen L, Murchie P.

Br J Gen Pract. 2016 Jul;66(648):e507-15. doi: 10.3399/bjgp16X685285. Epub 2016 May 9.

22.

A novel substituted aminoquinoline selectively targets voltage-sensitive sodium channel isoforms and NMDA receptor subtypes and alleviates chronic inflammatory and neuropathic pain.

Tabakoff B, Ren W, Vanderlinden L, Snell LD, Matheson CJ, Wang ZJ, Levinson R, Smothers CT, Woodward JJ, Honse Y, Lovinger D, Rush AM, Sather WA, Gustafson DL, Hoffman PL.

Eur J Pharmacol. 2016 Aug 5;784:1-14. doi: 10.1016/j.ejphar.2016.05.006. Epub 2016 May 5.

23.

A WEE1 Inhibitor Analog of AZD1775 Maintains Synergy with Cisplatin and Demonstrates Reduced Single-Agent Cytotoxicity in Medulloblastoma Cells.

Matheson CJ, Venkataraman S, Amani V, Harris PS, Backos DS, Donson AM, Wempe MF, Foreman NK, Vibhakar R, Reigan P.

ACS Chem Biol. 2016 Apr 15;11(4):921-30. doi: 10.1021/acschembio.5b00725. Epub 2016 Jan 8. Erratum in: ACS Chem Biol. 2016 Jul 15;11(7):2066-7.

PMID:
26745241
24.

Strategies and Approaches of Targeting STAT3 for Cancer Treatment.

Furtek SL, Backos DS, Matheson CJ, Reigan P.

ACS Chem Biol. 2016 Feb 19;11(2):308-18. doi: 10.1021/acschembio.5b00945. Epub 2016 Jan 15. Review.

PMID:
26730496
25.

Community pharmacy services for people with drug problems over two decades in Scotland: Implications for future development.

Matheson C, Thiruvothiyur M, Robertson H, Bond C.

Int J Drug Policy. 2016 Jan;27:105-12. doi: 10.1016/j.drugpo.2015.11.006. Epub 2015 Nov 27.

PMID:
26723885
26.

Structure-Based Screen Identification of a Mammalian Ste20-like Kinase 4 (MST4) Inhibitor with Therapeutic Potential for Pituitary Tumors.

Xiong W, Matheson CJ, Xu M, Backos DS, Mills TS, Salian-Mehta S, Kiseljak-Vassiliades K, Reigan P, Wierman ME.

Mol Cancer Ther. 2016 Mar;15(3):412-20. doi: 10.1158/1535-7163.MCT-15-0703. Epub 2015 Dec 31.

27.

Exploring the life-saving potential of naloxone: A systematic review and descriptive meta-analysis of take home naloxone (THN) programmes for opioid users.

McAuley A, Aucott L, Matheson C.

Int J Drug Policy. 2015 Dec;26(12):1183-8. doi: 10.1016/j.drugpo.2015.09.011. Epub 2015 Oct 1. Review.

PMID:
26508033
28.

The evolution of pharmaceutical care for drug misusers.

Robertson HD, Bond C, Matheson C.

Fam Pract. 2015 Dec;32(6):639-45. doi: 10.1093/fampra/cmv079. Epub 2015 Oct 25.

PMID:
26502811
29.

Pilot randomised controlled trial of Help4Mood, an embodied virtual agent-based system to support treatment of depression.

Burton C, Szentagotai Tatar A, McKinstry B, Matheson C, Matu S, Moldovan R, Macnab M, Farrow E, David D, Pagliari C, Serrano Blanco A, Wolters M; Help4Mood Consortium.

J Telemed Telecare. 2016 Sep;22(6):348-55. doi: 10.1177/1357633X15609793. Epub 2015 Oct 9.

PMID:
26453910
30.

Engaging the citizenship of the homeless-a qualitative study of specialist primary care providers.

Mills ED, Burton CD, Matheson C.

Fam Pract. 2015 Aug;32(4):462-7. doi: 10.1093/fampra/cmv036. Epub 2015 May 22.

PMID:
26002771
31.

RSK3: A regulator of pathological cardiac remodeling.

Martinez EC, Passariello CL, Li J, Matheson CJ, Dodge-Kafka K, Reigan P, Kapiloff MS.

IUBMB Life. 2015 May;67(5):331-7. doi: 10.1002/iub.1383. Epub 2015 May 19. Review.

32.

Evolutionary changes in the genome of Mycobacterium tuberculosis and the human genome from 9000 years BP until modern times.

Spigelman M, Donoghue HD, Abdeen Z, Ereqat S, Sarie I, Greenblatt CL, Pap I, Szikossy I, Hershkovitz I, Bar-Gal GK, Matheson C.

Tuberculosis (Edinb). 2015 Jun;95 Suppl 1:S145-9. doi: 10.1016/j.tube.2015.02.022. Epub 2015 Feb 13.

PMID:
25771203
33.

Allosteric inhibitors of the Eya2 phosphatase are selective and inhibit Eya2-mediated cell migration.

Krueger AB, Drasin DJ, Lea WA, Patrick AN, Patnaik S, Backos DS, Matheson CJ, Hu X, Barnaeva E, Holliday MJ, Blevins MA, Robin TP, Eisenmesser EZ, Ferrer M, Simeonov A, Southall N, Reigan P, Marugan J, Ford HL, Zhao R.

J Biol Chem. 2014 Jun 6;289(23):16349-61. doi: 10.1074/jbc.M114.566729. Epub 2014 Apr 22.

34.

Trifluoroacetic acid in 2,2,2-trifluoroethanol facilitates S(N)Ar reactions of heterocycles with arylamines.

Carbain B, Coxon CR, Lebraud H, Elliott KJ, Matheson CJ, Meschini E, Roberts AR, Turner DM, Wong C, Cano C, Griffin RJ, Hardcastle IR, Golding BT.

Chemistry. 2014 Feb 17;20(8):2311-7. doi: 10.1002/chem.201304336. Epub 2014 Jan 23.

PMID:
24458729
35.

Reducing drug related deaths: a pre-implementation assessment of knowledge, barriers and enablers for naloxone distribution through general practice.

Matheson C, Pflanz-Sinclair C, Aucott L, Wilson P, Watson R, Malloy S, Dickie E, McAuley A.

BMC Fam Pract. 2014 Jan 15;15:12. doi: 10.1186/1471-2296-15-12.

36.

Public opinion of drug treatment policy: exploring the public's attitudes, knowledge, experience and willingness to pay for drug treatment strategies.

Matheson C, Jaffray M, Ryan M, Bond CM, Fraser K, Kirk M, Liddell D.

Int J Drug Policy. 2014 May;25(3):407-15. doi: 10.1016/j.drugpo.2013.11.001. Epub 2013 Nov 17.

PMID:
24332456
37.

Model system for irreversible inhibition of Nek2: thiol addition to ethynylpurines and related substituted heterocycles.

Lebraud H, Coxon CR, Archard VS, Bawn CM, Carbain B, Matheson CJ, Turner DM, Cano C, Griffin RJ, Hardcastle IR, Baisch U, Harrington RW, Golding BT.

Org Biomol Chem. 2014 Jan 7;12(1):141-8. doi: 10.1039/c3ob41806e. Epub 2013 Nov 8.

PMID:
24213855
38.

Does training in motivational interviewing for community pharmacists improve outcomes for methadone patients? A cluster randomised controlled trial.

Jaffray M, Matheson C, Bond CM, Lee AJ, McLernon DJ, Johnstone A, Skea L, Davidson B.

Int J Pharm Pract. 2014 Feb;22(1):4-12. doi: 10.1111/ijpp.12049. Epub 2013 Jul 3.

PMID:
23822820
39.

Spina bifida in a pre-Columbian Cuban population: A paleoepidemiological study of genetic and dietary risk factors.

Armstrong S, Cloutier L, Arredondo C, Roksandic M, Matheson C.

Int J Paleopathol. 2013 Mar;3(1):19-29. doi: 10.1016/j.ijpp.2013.01.004. Epub 2013 Mar 9.

PMID:
29539356
40.

Hominin dispersal into the Nefud Desert and Middle palaeolithic settlement along the Jubbah Palaeolake, Northern Arabia.

Petraglia MD, Alsharekh A, Breeze P, Clarkson C, Crassard R, Drake NA, Groucutt HS, Jennings R, Parker AG, Parton A, Roberts RG, Shipton C, Matheson C, Al-Omari A, Veall MA.

PLoS One. 2012;7(11):e49840. doi: 10.1371/journal.pone.0049840. Epub 2012 Nov 19.

41.

Prevalence of common chronic respiratory diseases in drug misusers: a cohort study.

Palmer F, Jaffray M, Moffat MA, Matheson C, McLernon DJ, Coutts A, Haughney J.

Prim Care Respir J. 2012 Dec;21(4):377-83. doi: 10.4104/pcrj.2012.00069.

42.

Validation of a small animal model for soft tissue filler characterization.

Hillel AT, Nahas Z, Unterman S, Reid B, Axelman J, Sutton D, Matheson C, Petsche J, Elisseeff JH.

Dermatol Surg. 2012 Mar;38(3):471-8. doi: 10.1111/j.1524-4725.2011.02273.x. Epub 2012 Feb 15.

PMID:
22335613
43.

A pilot randomised controlled trial of brief versus twice weekly versus standard supervised consumption in patients on opiate maintenance treatment.

Holland R, Matheson C, Anthony G, Roberts K, Priyardarshi S, Macrae A, Whitelaw E, Appavoo S, Bond C.

Drug Alcohol Rev. 2012 Jun;31(4):483-91. doi: 10.1111/j.1465-3362.2011.00394.x. Epub 2011 Dec 12.

PMID:
22150819
44.

Photoactivated composite biomaterial for soft tissue restoration in rodents and in humans.

Hillel AT, Unterman S, Nahas Z, Reid B, Coburn JM, Axelman J, Chae JJ, Guo Q, Trow R, Thomas A, Hou Z, Lichtsteiner S, Sutton D, Matheson C, Walker P, David N, Mori S, Taube JM, Elisseeff JH.

Sci Transl Med. 2011 Jul 27;3(93):93ra67. doi: 10.1126/scitranslmed.3002331.

45.

Methadone prescribing under supervised consumption on premises: a Scottish clinician's perspective on prescribing practice.

Anthony GB, Matheson CI, Holland R, Bond C, Roberts K, Rae AM, Whitelaw E, Priyadarshi S.

Drug Alcohol Rev. 2012 May;31(3):342-7. doi: 10.1111/j.1465-3362.2011.00316.x. Epub 2011 Jul 5.

PMID:
21726308
46.

Correcting an error but inadequate treatment of cervical cancer still occurred.

Matheson C.

N Z Med J. 2010 Sep 24;123(1323):83. No abstract available.

PMID:
20930917
47.

A patient's response to recent criticisms of the findings in the report of the Cervical Cancer Inquiry 1988.

Matheson C.

N Z Med J. 2010 Aug 27;123(1321):95-101. No abstract available.

PMID:
20927164
48.

Management of drug misuse: an 8-year follow-up survey of Scottish GPs.

Matheson C, Porteous T, van Teijlingen E, Bond C.

Br J Gen Pract. 2010 Jul;60(576):517-20. doi: 10.3399/bjgp10X514783.

49.
50.

Titanic's unknown child: the critical role of the mitochondrial DNA coding region in a re-identification effort.

Just RS, Loreille OM, Molto JE, Merriwether DA, Woodward SR, Matheson C, Creed J, McGrath SE, Sturk-Andreaggi K, Coble MD, Irwin JA, Ruffman A, Parr RL.

Forensic Sci Int Genet. 2011 Jun;5(3):231-5. doi: 10.1016/j.fsigen.2010.01.012. Epub 2010 Apr 2.

PMID:
20457081

Supplemental Content

Loading ...
Support Center